After a long R&D process HelixPharma's Team is proud to announce that the own active substance called GlicoPro has been used for the eyedrop "Lacricomplex". The company expresses all its satisfaction in seeing one of its assets used in a Medical Device that for the unique characteristics scientifically validated by the University of Ferrara will represent an innovation in the treatment of the Dryeye.